首页> 外文期刊>BioProcess International >Take Complexity and Risk Out of Regulatory Compliance
【24h】

Take Complexity and Risk Out of Regulatory Compliance

机译:Take Complexity and Risk Out of Regulatory Compliance

获取原文
获取原文并翻译 | 示例
           

摘要

Novo Nordisk Pharmatech's high-purity, nontherapeutic insulin is sourced directly from the Novo Nordisk parent company, the world's largest insulin producer. The product consists of insulin human crystals that are biosynthetically produced by recombinant microbial expression in yeast.Insulin human AF stimulates the proliferation of cells and enhances the yield, and it is a key component in serum-free growth media for mammalian cells. Insulin human AF is used for manufacturing monoclonal antibodies, virus vaccines, gene therapies, andother biological drug products approved by regulatory agencies worldwide, including FDA and EMA.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号